MedVenture Partners

A-Wave is a manufacturing company specializing in medical devices. It develops and markets innovative solutions, including a remote medical treatment system featuring a wristwatch-type wearable device. This device detects cardiac murmurs, reduced activity, and peripheral colds, enabling early symptom detection of heart failure in patients at home.

A-Wave is a manufacturing company specializing in medical devices. It develops and markets innovative solutions, including a remote medical treatment system featuring a wristwatch-type wearable device. This device detects cardiac murmurs, reduced activity, and peripheral colds, enabling early symptom detection of heart failure in patients at home.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Avisi Technologies Inc. is a Philadelphia-based company founded in 2017 that specializes in developing innovative solutions for glaucoma treatment. Its primary product, VisiPlate, is a next-generation, nanotechnology-enabled aqueous shunt designed to prevent blindness caused by glaucoma. Through its advanced technology, Avisi Technologies aims to enhance the effectiveness of glaucoma management and improve patient outcomes.

mediVR specializes in the development and sale of a therapeutic medical device that employs virtual reality, three-dimensional tracking, and artificial intelligence technologies. Its flagship product, mediVR Kagura, is a self-exercise device designed to evaluate and improve motor function, posture balance, and cognitive function required for walking. The company markets its device through distributors.

CorVista Health, Inc. is an innovative medical technology company specializing in artificial intelligence-based digital health and medical imaging solutions, particularly for coronary artery and pulmonary hypertension diseases. The company has developed a non-invasive cardiac diagnostic platform that allows physicians to assess heart function without the need for radiation, contrast agents, injections, fasting, or exercise. This portable device, which can operate using WiFi or cellular signals, is designed for point-of-care environments such as doctors' offices, satellite clinics, nursing homes, and mobile settings. Founded in 2012 and headquartered in Toronto, Canada, CorVista Health also maintains additional offices in Cary, North Carolina, and Shanghai, China. The firm's approach integrates advanced mathematics, physics, artificial intelligence, and cloud computing to enhance cardiovascular diagnostics.

Alivas is a medical device company based in Tokyo, Japan, that develops a therapeutic device to treat refractory constipation. Founded in 2017, the company aims to provide a treatment option for patients with intractable chronic constipation. It is described as a joint venture between Stanford University and the University of Tokyo, in collaboration with the Japan Biodesign program for innovative medical device creation.

Alivas is a medical device company based in Tokyo, Japan, that develops a therapeutic device to treat refractory constipation. Founded in 2017, the company aims to provide a treatment option for patients with intractable chronic constipation. It is described as a joint venture between Stanford University and the University of Tokyo, in collaboration with the Japan Biodesign program for innovative medical device creation.

SonoMotion Inc. develops non-invasive medical devices for kidney stone disease, including Break Wave for fragmenting large stones and Stone Clear to remove fragments within about 15 minutes in office settings without general anesthesia or X-ray radiation. The company, founded in 2012 and based in San Mateo, California, focuses on office-based procedures that aim to simplify treatment, reduce hospital visits, and offer cost-efficient care for kidney stone patients.

PaMeLa Co., Ltd. is a medical device company based in Suita, Japan, founded in 2016. The company focuses on developing innovative technology to measure pain experienced by patients during surgical procedures. By utilizing brain wave analysis, algorithms, and machine learning, PaMeLa aims to create an objective method for quantifying pain. This approach is intended to enhance medical care by providing a scientific basis for pain assessment, thereby improving patient outcomes and treatment strategies.

DO THE SAMURAI, Inc. is a cultural tourism platform based in Tokyo, Japan, founded in 2016. The company operates Hotokami, a website and mobile application that serves as a comprehensive directory for shrines and temples throughout Japan. This platform allows users to easily search for and access information about these historical sites, facilitating travel planning for worshippers and tourists alike. By providing a space for users to post experiences, share visits, and exchange information, DO THE SAMURAI enhances engagement with Japan's rich cultural heritage.

A-Traction Inc. is a Japanese company based in Kashiwa, Chiba, specializing in the development of surgical robots designed for laparoscopic surgery. Founded in 2015, A-Traction aims to enhance surgical precision and safety through innovative medical devices. The company has introduced a concept called ANSUR, wherein the robotic system acts as a collaborative partner to the surgeon during procedures, facilitating smoother and more effective operations. By leveraging advanced technology and a unique approach to robotic assistance, A-Traction seeks to provide high-quality surgical solutions that improve outcomes for patients while ensuring a safer surgical environment.

BMG is a medical company specializing in the development, manufacturing, and sales of biomedical polymer materials and medical devices. The company focuses on creating innovative biomaterial products, including biodegradable and absorbable polymer materials intended for medical applications. BMG's offerings include domestically produced polymers for bioabsorbable sutures, which provide patients with effective alternatives that enhance health outcomes. Through its research and development services, BMG aims to contribute to advancements in the medical field and improve the overall well-being of individuals globally.

A-Traction Inc. is a Japanese company based in Kashiwa, Chiba, specializing in the development of surgical robots designed for laparoscopic surgery. Founded in 2015, A-Traction aims to enhance surgical precision and safety through innovative medical devices. The company has introduced a concept called ANSUR, wherein the robotic system acts as a collaborative partner to the surgeon during procedures, facilitating smoother and more effective operations. By leveraging advanced technology and a unique approach to robotic assistance, A-Traction seeks to provide high-quality surgical solutions that improve outcomes for patients while ensuring a safer surgical environment.

Biomedical Solutions Company, established in 2012 in Tokyo, Japan, specializes in the research and development of neurovascular intervention devices. The company focuses on creating high-quality medical equipment, prioritizing both safety and efficacy, to meet the needs of its clients. Its flagship product is a cerebrovascular thrombus removal device, designed to treat acute cerebral infarction, offering improved visibility and low friction for enhanced patient care.